Ravichandran, A., Thomas, M., Marroquin, R. M., Dworkin, E., Patel, A. A. (2026). Response to HiDAC/mitoxantrone/venetoclax (HMV) in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6527